S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Eliem Therapeutics (ELYM) Earnings Date, Estimates & Call Transcripts

$3.85
-0.33 (-7.89%)
(As of 04/19/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ELYM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELYM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ELYM Earnings Date and Information

Eliem Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Eliem Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
11/14/2023Q3 2023-($0.15)($0.15)($0.15)--
8/10/2023Q2 2023-($0.19)($0.19)($0.19)--
5/11/2023Q1 2023($0.28)($0.84)($0.56)($0.84)--
3/6/2023Q4 2022($0.44)($0.29)+$0.15($0.29)--
11/14/2022Q3 2022($0.42)($0.37)+$0.05($0.37)--
8/15/2022Q2 2022($0.47)($0.52)($0.05)($0.48)--
5/16/2022Q1 2022($0.57)($0.50)+$0.07($0.50)--
3/7/2022Q4 2021($0.70)($0.40)+$0.30($0.40)--
11/8/2021Q3 2021($0.89)($0.70)+$0.19($0.70)--
9/13/2021Q2 2021($2.37)($3.11)($0.74)($3.11)--

Eliem Therapeutics Earnings - Frequently Asked Questions

When is Eliem Therapeutics's earnings date?

Eliem Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on ELYM's earnings history.

How much profit does Eliem Therapeutics generate each year?

Eliem Therapeutics (NASDAQ:ELYM) has a recorded net income of -$35.12 million. ELYM has generated -$1.47 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:ELYM) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners